HYPNOTIL (TEMAZEPAM) 30MG BY P.D.H. PHARMA / STRIP

$395.00

  • 100 STRIPS HYPNOTIL (TEMAZEPAM) 30 MG BY P.D.H. PHARMA = US$395
  • 500 STRIPS HYPNOTIL (TEMAZEPAM) 30MG BY P.D.H. PHARMA = US$1,975  
  • 1000 STRIPS HYPNOTIL (TEMAZEPAM) 30 MG BY P.D.H. PHARMA = US$3,950 
  • 5000 STRIPS HYPNOTIL (TEMAZEPAM) 30 MG BY P.D.H. PHARMA = US$19,750 
Compare

Description

Product Description

Hypnotil (Temazepam) 30mg is a white, crystalline substance, very slightly soluble in water and sparingly soluble in alcohol USP. Restorilâ„¢ (temazepam) capsules, 7.5 mg, 15 mg, 22.5 mg, and 30 mg, are for oral administration. 7.5 mg, 15 mg, 22.5 mg, and 30 mg Capsules Active Ingredient: temazepam USP 7.5 mg Capsules Inactive Ingredients: FD&C Blue #1, FD&C Red #3, gelatin, lactose, magnesium stearate, red iron oxide, titanium dioxide. May also include: n-butyl alcohol, iron oxide red, shellac, shellac glaze, SD-35A alcohol. 15 mg Capsules Inactive Ingredients: FD&C Blue #1, FD&C Red #3, gelatin, lactose, magnesium stearate, red iron oxide, titanium dioxide. May also include: n-butyl alcohol, FD&C Blue #1 / Brilliant Blue FCF Aluminum Lake, iron oxide red, isopropyl alcohol, propylene glycol, shellac, shellac glaze, SD-35A alcohol, SD-45 alcohol. 22.5 mg Capsules Inactive Ingredients: FD&C Blue #1, FD&C Red #3, gelatin, lactose, magnesium stearate, red iron oxide, titanium dioxide. May also include: n-butyl alcohol, FD&C Blue #1 / Brilliant Blue FCF Aluminum Lake, iron oxide red, isopropyl alcohol, propylene glycol, shellac, shellac glaze, SD-35A alcohol, SD-45 alcohol. 30 mg Capsules Inactive Ingredients: FD&C Blue #1, FD&C Red #3, gelatin, lactose, magnesium stearate, red iron oxide, titanium dioxide. May also include: n-butyl alcohol, FD&C Blue #1 / Brilliant Blue FCF Aluminum Lake, iron oxide red, isopropyl alcohol, propylene glycol, shellac, shellac glaze, SD-35A alcohol, SD-45 alcohol.

Reviews

There are no reviews yet.

Be the first to review “HYPNOTIL (TEMAZEPAM) 30MG BY P.D.H. PHARMA / STRIP”

Your email address will not be published. Required fields are marked *

X